Appointment of LingZhi Enterprise Financing as an independent financial advisor for DRAGON RISE GP (06829)
Longsheng Group Holdings (06829) announced that Lingzhi Enterprise Financing Limited (a company incorporated under the Securities and Futures Ordinance...)
The announcement of DRAGON RISE GP (06829) states that Leading Wisdom Corporate Finance Limited (a licensed corporation regulated under the Securities and Futures Ordinance to provide advice on corporate finance to institutional clients) has been appointed as an independent financial advisor. They will provide advice to the independent directors' committee and independent shareholders on whether the terms of the stock offering, placement agreement, and underwriting agreement are in line with general commercial terms, fair and reasonable, and in the overall interests of independent shareholders. They will also provide advice on how independent shareholders should vote. This appointment has been approved by the independent directors' committee in accordance with the relevant listing rules.
Related Articles

HK Stock Market Move | Coal stocks rose in the morning. Raw coal production in August has decreased year-on-year for two consecutive months. It is expected that the growth rate of production for the whole year will narrow.

HK Stock Market Move | XPENG-W (09868) rose more than 4% in early trading, becoming the top seller of pure electric vehicles in 32 markets.

Ideal Car (02015) and Contemporary Amperex Technology (03750) have reached a comprehensive strategic cooperation.
HK Stock Market Move | Coal stocks rose in the morning. Raw coal production in August has decreased year-on-year for two consecutive months. It is expected that the growth rate of production for the whole year will narrow.

HK Stock Market Move | XPENG-W (09868) rose more than 4% in early trading, becoming the top seller of pure electric vehicles in 32 markets.

Ideal Car (02015) and Contemporary Amperex Technology (03750) have reached a comprehensive strategic cooperation.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025